48 completed, 16 unknown, 8 terminated, 3 not yet recruiting. 22 Not applicable, 18 Phase 1, 13 Phase 3, 12 Phase 2, 12 Phase 4.
Follow Erythromycin: new trials by email Literature Review of Erythromycin trials Research Report on Erythromycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PLatform for Adaptive Trials In Perinatal UnitS - [Core Protocol] Erythromycin, Amoxicillin and Erythromycin, Azithromycin - Preterm Birth | Not applicable | Not yet recruiting | University of Melbourne | 100000 | 2025-11-01 | 2025-06-13 |
| Preterm Rupture of Membranes Optimising Antibiotics Trial Erythromycin 250mg + placebo, Azithromycin 500mg + placebo, Erythromycin 250mg and Amoxicillin 500mg - PPROM, Preterm | Not applicable | Not yet recruiting | University of Melbourne | 3900 | 2025-09-01 | 2025-04-02 |
| Efficacy Of Erythromycin Phonophoresis on Chronic Rhinosinusitis Erythromycin Phonophoresis, Ultrasound (US), Topical Erythromycin - Chronic Rhinosinusitis | Not applicable | Not yet recruiting | Cairo University | 90 | 2025-07-07 | 2025-07-14 |
| A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants AZD5004, Rosuvastatin, Erythromycin - Healthy Participants | Phase 1 | Completed | AstraZeneca | 49 | 2025-05-06 | 2025-10-10 |
| A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood BI 1291583, erythromycin - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 20 | 2025-04-29 | 2025-09-16 |
| Clinical Observations of Pain and Pruritus Induced by Exposure to Allergic Contact Dermatitis Caused by Macrolides Erythromycin, Azithromycin, physiological saline - Dermatitis, Allergic Contact | Unknown | Affiliated Hospital of Nantong University | 30 | 2024-09-01 | 2024-08-27 | |
| Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT) Ceftriaxone 1000 MG, Clarithromycin 500mg, Metronidazole 500 mg - Preterm Premature Rupture of Membrane, Pregnancy, High Risk | Phase 4 | Recruiting | Ohio State University | 56 | 2024-07-18 | 2026-01-27 |
| Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management Erythromycin, Azithromycin - Pre-term Premature Rupture of Membranes | Phase 1 | Completed | District Headquarters Teaching Hospital Sahiwal | 250 | 2024-04-01 | 2026-02-06 |
| Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers CHF6001 DPI, Erythromycin - Chronic Obstructive Pulmonary Disease | Phase 1 | Completed | Chiesi Farmaceutici S.p.A. | 24 | 2024-03-28 | 2024-07-03 |
| Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes Erythromycin, Azithromycin - Premature Rupture of Membrane | Phase 3 | Active not recruiting | Inova Health Care Services | 140 | 2024-03-08 | 2026-10-15 |
| A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults TAK-279, Erythromycin, Phenytoin - Healthy Volunteers | Phase 1 | Completed | Takeda | 172 | 2023-08-11 | 2024-02-06 |
| Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) Rina-S, Carboplatin, Bevacizumab - High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer | Phase 1 / Phase 2 | Recruiting | Genmab | 952 | 2022-12-07 | 2026-10-07 |
| A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B) SAR443820, Erythromycin ethyl succinate, Itraconazole - Amyotrophic Lateral Sclerosis, Healthy Volunteer | Phase 1 | Completed | Sanofi | 16 | 2022-02-18 | 2025-01-03 |
| Erythromycin in Septic Patients: Immunomodulatory Role and Clinical Impact Erythromycin - Sepsis, Septic Shock | Not applicable | Completed | Tunis University | 110 | 2022-01-01 | 2023-05-12 |
| Impact of Prokinetic Use After Emergency Intestinal Anastomosis on Postoperative Clinical Outcomes Prokinetic Motility Agents as primpiram and gastreg - Prokinetic Use After Emergency Intestinal Anastomosis | Not applicable | Unknown | Sohag University | 15 | 2022-01-01 | 2022-05-03 |
| Effect of Metoclopramide Versus Erythromycin on on Gastric Residual Volume Erythromycin (400mg), metoclopramide (10mg), naturally flavored water - Gastric Residual Volume | Not applicable | Completed | Cairo University | 50 | 2021-03-01 | 2025-01-14 |
| A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult Men Relugolix/E2/NETA FDC, Relugolix, Erythromycin - Healthy | Phase 1 | Completed | Myovant Sciences GmbH | 43 | 2021-01-06 | 2021-09-01 |
| Long-term Prognosis of Children With Bronchiectasis Treated With Low-dose Erythromycin Intervention erythromycin - Bronchiectasis | Not applicable | Unknown | Beijing Children's Hospital | 70 | 2019-08-01 | 2019-08-28 |
| Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan ciprofloxacin - Bacterial Infections, Antibiotic Resistant Infection | Completed | Yarmouk University | 24 | 2019-08-01 | 2021-11-04 | |
| Intradermal LPS and Antibiotics Erythromycin 4% topical gel formulation:, Clindamycin 1% lotion formulation:, Prednisolone tablet (0.5mg/kg; parallel comparison): - Inflammation; Skin | Not applicable | Completed | Centre for Human Drug Research, Netherlands | 32 | 2018-10-12 | 2021-08-03 |
Showing 20 of 81. Sign in to see all of them.
Premature Birth (6) · Preterm Premature Rupture of the Membranes (5) · Pneumonia (4) · Chorioamnionitis (3) · Gastroparesis (3) · Surgical Wound Infection (3) · Adenomatous Polyposis Coli (2) · Bronchiectasis (2) · Carcinoma, Non-Small-Cell Lung (2) · Feeding and Eating Disorders (2) · Fetal Membranes, Premature Rupture (2) · Gastrointestinal Hemorrhage (2) · HIV Infections (2) · Hematemesis (2) · Obesity (2)
Beijing Children's Hospital (3) · Universitaire Ziekenhuizen KU Leuven (3) · Baqiyatallah Medical Sciences University (2) · Boehringer Ingelheim (2) · Cairo University (2) · Centre for Human Drug Research, Netherlands (2) · Indiana University (2) · Janssen Research & Development, LLC (2) · Pfizer (2) · University of Melbourne (2) · michal roll (2) · AIO-Studien-gGmbH (1) · Adil Bharucha (1) · Affiliated Hospital of Nantong University (1) · AstraZeneca (1)
United States (30) · China (5) · Belgium (4) · Spain (4) · Egypt (3) · United Kingdom (3) · Brazil (2) · Bulgaria (2) · France (2) · Germany (2) · Iran (2) · Netherlands (2) · Russia (2) · Saudi Arabia (2) · South Korea (2)
A-Dong Shen, Master (2) · Clare Whitehead, MBChB, PhD (2) · Adil E Bharucha, MBBS, MD (1) · Antonio Saad, MD, MBA (1) · Antonio Soriano, M D, Ph D (1) · Aya Gamal Fawzy Elsayed, PhD (1) · B. T. Walsh, MD (1) · Baharak Moshiree, MD (1) · Bao-Ping Xu, MD (1) · Brett Manley, MBBS, PhD (1) · Brian Mercer, M.D. (1) · Carlos A Caramori (1)
PMID 15276398, PMID 15840453, PMID 16227794, PMID 16522393, PMID 16875654, PMID 16978651, PMID 17267841, PMID 17978109, PMID 18295116, PMID 18723437, PMID 19588358, PMID 19664210, PMID 20018966, PMID 21145052, PMID 21447772, PMID 22530208, PMID 23254142, PMID 24380989, PMID 25155587, PMID 25628457, PMID 26083537, PMID 26289222, PMID 26755499, PMID 26817505, PMID 27880079, PMID 28134617, PMID 28281228, PMID 29507070, PMID 29635488, PMID 30962334, PMID 31000676, PMID 31244327, PMID 32129861, PMID 33020163, PMID 38359518, PMID 38932723, PMID 39855752, PMID 4902833, PMID 8948280
2015 (1), 2017 (1), 2023 (1), P01DK068055 (1), R01GM067308 (1), R01MH042206 (1), UL1TR000135 (1)